Shizuoka, Japan

Naoshi Horiba

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naoshi Horiba: Innovator in Pharmaceutical Development

Introduction

Naoshi Horiba is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating various medical conditions.

Latest Patents

Horiba holds a patent for a dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same. This invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt. It includes a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification. The compound serves as an active ingredient, along with a method for prevention and/or treatment.

Career Highlights

Horiba is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work has been instrumental in advancing the company's research and development efforts in innovative drug therapies.

Collaborations

Throughout his career, Horiba has collaborated with notable colleagues, including Yoshihito Ohtake and Naoki Okamoto. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Naoshi Horiba's contributions to pharmaceutical innovation exemplify the impact of dedicated inventors in the medical field. His work continues to pave the way for advancements in treatment options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…